Heart age app trial tests digital nudge against cardiovascular disease
NCT ID NCT05827861
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial in Singapore tested whether telling people their 'heart age' and giving them a behavior-change app (HOPE-CVD) could lower their risk of heart disease. Over 1,100 adults aged 30-74 with at least a 5% risk were split into four groups, each receiving different levels of risk information and app support. The study measured changes in predicted heart risk, blood pressure, cholesterol, and healthy behaviors after six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HeartAge risk presentation and HOPE-CVD mobile app (behavioral interventions)
What this could lead to
If successful, this approach could provide a simple, scalable way to help people lower their heart disease risk using personalized risk communication and digital behavior support.
What could go wrong
The trial is completed but results are not yet published, so we don't know if it worked. It also excluded people needing medication, so findings may not apply to higher-risk groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National University of Singapore
Singapore, Singapore, 117549, Singapore